TAUNS Laboratories, Inc.
197A.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥58,193 | ¥54,903 | ¥50,872 | ¥63,150 |
| - Cash | ¥4,610 | ¥9,267 | ¥8,581 | ¥7,573 |
| + Debt | ¥19,509 | ¥14,424 | ¥13,632 | ¥13,315 |
| Enterprise Value | ¥73,092 | ¥60,060 | ¥55,923 | ¥68,892 |
| Revenue | ¥2,368 | ¥1,020 | ¥5,627 | ¥5,561 |
| % Growth | 132.2% | -81.9% | 1.2% | – |
| Gross Profit | ¥1,630 | ¥90 | ¥3,964 | ¥3,910 |
| % Margin | 68.8% | 8.8% | 70.5% | 70.3% |
| EBITDA | ¥739 | -¥876 | ¥2,986 | ¥2,967 |
| % Margin | 31.2% | -85.8% | 53.1% | 53.4% |
| Net Income | ¥358 | -¥330 | ¥1,959 | ¥1,990 |
| % Margin | 15.1% | -32.4% | 34.8% | 35.8% |
| EPS Diluted | 3.33 | -3.05 | 17.94 | 18.55 |
| % Growth | 209.2% | -117% | -3.3% | – |
| Operating Cash Flow | – | ¥0 | ¥0 | ¥0 |
| Capital Expenditures | – | ¥0 | ¥0 | ¥0 |
| Free Cash Flow | – | ¥0 | ¥0 | ¥0 |